Trial Profile
A Phase 3, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary)
- Indications Constipation; Postoperative ileus
- Focus Therapeutic Use
- Sponsors Bausch Health Companies; Salix Pharmaceuticals
- 17 Sep 2014 New trial record